Hyperactive Ras signaling is the main driving event caused by somatic mutations in KRAS, NRAS, or PTPN11 in about 50% of JMML patients (Tartaglia et al., 2004; Lipka et al., 2017). Here, NRAS is linked to juvenile myelomonocytic leukemia.